PBS NewsHour

Expert weighs in on vaccine efficacy against omicron variant

Clip: 11/30/2021 | 8m 16s | Video has closed captioning.

A growing number of countries are reporting cases of the coronavirus' omicron variant, and many are mandating travel bans. Meanwhile, advisors to the U.S. Food and Drug Administration have now endorsed drug maker Merck's pill to treat COVID-19 in high-risk adults. All of this comes as public health officials are emphasizing the need for global cooperation. Nick Schifrin reports.

Aired: 11/30/21

Rating: NR

Problems Playing Video? | Closed Captioning

Major corporate funding for the PBS NewsHour is provided by BNSF, Consumer Cellular, Leidos, Babbel, and Raymond James. Funding for the PBS NewsHour Weekend is provided by Mutual of America. …